Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So to understand the UK Food Standards Agency(FSA) is the government agency for the U.K. as to food additives and the opening to food supplement markets in the U.K.- world wide about 150 billion$ currently, the U.K. is expected to be 15 Billion$ by 2023....6 million people in the U.K.(>< 10% in the U.K.) currently have tried or use or regularly use CBDs, thus the interest of the Toxicity evaluations about January 28th 2020 meeting between the CTA( 1000+ members) and FSA.
Cannabis Trades Association (CTA)(Primarily based in the U.K.) is the said 2nd tier to European Industrial Hemp Association(EIHA)( https://eiha.org/)of which Dragonfly Bioscience is a member of both as are all the larger operations in the greater E.U. community of CBD providers.
'As the largest cannabis trade body globally, Cannabis Trades Association (CTA), operating in the sector for 4 years now and with over 1000 members, the CTA is being commended on its sensible approach to compliance and the valuable support it provides its members and the industry as a whole.
"...products that fall within the scope of the Article 4 submission by The CTA (its members’ products) would, therefore, be completely isolated and protected from enforcement, following the determination that they are indeed not novel."
As the largest cannabis trade body globally, operating in the sector for 4 years now and with over 1000 members, the CTA is being commended on its sensible approach to compliance and the valuable support it provides its members and the industry as a whole.'
1000 members of a two tiered association to including most independent shop owners up to 'door' operators like the CHarlottesweb and Dragonfly, U.S. participators, E.U. and Canadian that are or want to operate in the E.U. and the U.K. is something of a turning point as to how the industry may get some self regulation.
Org members are shooting to get food additives approved as high as 200mg(1/5th gram perday) suggested limit per day, but the meeting intent is to get get food additives approved via self regulating through the Org instead of government operations on the basis of purity(no metals pesticides ect) and advertising labels(no medical claims). Going to be several other CBD and Meds meetings outside of regulation channels so here's to hoping good news for everybody at those industry events. Then Feb 1st comes supposed Brexit, so other changes may happen also!
A week><? till next update?... In January, I think around the 28th there will be a U.K. meeting for U.K. 'Toxic' requalification in one of the relevant U.K. agencies and the attendees will include a set of CBD participants including all the big players, even Charlottesweb and the StillCanna agreement partner,,, Dragonfly Biosciences and the Orgs at the meeting represent 1000 other companies in this particular space(CBDs) participant. They are appealing bad science included references to the 'mouse study' I mentioned earlier(eqeuvelent dosing 1.4, 4.2 and 14 grams per day test to find absolute toxicity)
DragonFly and the other U.K. paricipators and those wishing to participate in the U.K. markets(like Aurora, Dragonfly,
Charlottesweb, Columbia Care, Mile High.. etcetera.. are using another avenue in line with Novel Foods/E.U. desired guidelines so to be hitting regulation from both directions at the same time.
The new Association for the Cannabinoid Industry (ACI)(https://www.theaci.co.uk/our-members/) is made up of roughly 25 companies from Europe and North America. The companies vow to “foster full compliance” with European Union rules that say CBD shouldn’t be sold as a food ingredient without first having premarketing authorization because CBD is a “novel food.”
ACI’s parent group, is the London-based Centre For Medicinal Cannabis (CMC), the commitment of ACI members to apply for
authorization could ease enforcement against member companies selling CBD. In addition to applying for authorization, ACI members have committed to eliminating detectable THC and adhering to testing and labeling standards and marketing ethics.... which is just like the afformentioned.. Cannabis Trades Association (CTA)(Primarily based in the U.K.) is the said 2nd tier to European Industrial Hemp Association(EIHA)(1000 membership).
The ACI Charter, is working towards the introduction of a kitemark(Kitemark is a UK product and service quality trade mark which is
owned and operated by The British Standards Institution) to display on CBD products to provide consumers with reassurance that their purchase is meeting the regulations and the CTA group both have Dragonfly Biosciences as members to move whatever process of.....
regulation is most preffered in the U.K...
One estimate says that the CBD market will generate $20 billion by 2024; another argues that this study is, in fact, too
conservative, and that CBD will actually hit $22 billion by 2022. Which ever sum total... Still is Dragonfly's Isolate supplier and
......will get a portion of those revenues.
Fwiw, I've got a bid in... I wouldn't be surprised to hear 3x or 4X times sales previous totals in a month/after last 1.2 mill in committed buys.
Indications to me is that the Nexus plant will have some 30 million+ in revenues over the next year... pretty sure the Horizon plant in Poland will go ahead that should bring 6 times the Nexus plant. To be built late spring and summer 2020. While the company is still largely under the radar because people are not aware of what "Isolate", the company major effort, is, and that many of the mass distributers have few producers of size and quality and are not aware of the cost for getting a sizable operation running that keeps small and most medium size competators from building a plant specifically capable for Isolate CBD.
The domination of 'pot socks' in that sector was a run of companies trying to grab as much of the market areas as possible and are now not profitable because of buying way overpriced operators, buildouts, 'door access' and are going to have some terrible write-downs for those assets- goodwill. Almost all the 'pot' leaders will not be profitable till 2022- and more dilutions of company values as to their stocks.
Operating profits are coming to the forefront of concerns for the Pot stocks...
meanwhile on the CBD side of Cannabis and Isolate and even 'syrup'/honey' production hasn't the mass employee to production cost or other expenses and taxations 'Pot" has.
Imo, inevitably the specializing in just a couple production items as Stillcanna is doing and leaving the 'shelf'/store responsibility/expense to resellers as much as possible is the way to go...
Those 'pot' stock leaders will do better simply buying produced product for markup, Isolate, than go further into debt as the CBD markets grow exponentially.
Anyone want in just before sales starts happening.. first move of a first mover?!
Thanks Mle660, I've been bugging for Form 7s and those will be caught up also. So we we've been told and verified about cash in hand to probably get through 2020 entirely and with sales that will expand. I've been told orders for agreements are being packaged along with samples for new customers potentials. Looks like in the filings, ongoing profits are covered as to taxations, substantially by purchases of prior entities and Polish profits are covered substantially in Poland also.
With the one shift at Nexus ongoing now for 440 kilos per month production I figure the company can have >< 10 cents per share(diluted) in earnings "before"... off that production capacity at present.
Even if they sold their production close to half the average kilo pricing to open their markets they could get >< 5 cents per. The next 3-4 months will tell the tale.('Rubber meets the road" time)
My figures still show that the Origin and Nexus and yet to be built Horizon plant(Construction scheduled for initiation in >< 5 months) can create, all told, somewhere WELL over 50 cents a share in 'before" PROFITS.
Fwiw, RBC Capitol Investment traders seem to have gotten in the stock so "deeper pockets" are interested now, even before sales have started:)
Some DD on Olimax via a 2017 interview done locally.. helps explain why Stil bought Olimax, the ladies, equipment purchased, the Polish Hemp Subsidy from at its base...
https://innpoland.pl/134041,polska-krolowa-konopi-pochodzi-z-podkieleckiej-wsi-to-jedyna-roslina-z-ktorej-mozna-tak-wiele-uzyskac
So... 'The NEXUSfacility has successfully processed the required quantity of raw hemp biomass in an 8-hour shift to meet its 1320-kilo a month of Pharma Grade CBD Isolate based on 3 shifts' means one shift(present)…= 440 kilo ongoing/per month= (@30 days a month) 14 kilos a day(present)= ????????????$. The prices currently are running ><3000$ bulk sales per kilo worldwide averages. General market value may be stated then >< 40k$.. per day production value(present). Yearly one shift >< 12 million for one plant Nexus. '780' ongoing production cost estimates is 4 million(-) on the 12 million(+)= 8million before 'EBITDA'(present/one shift/one plant)=?per share?= ><7 cents (present/one shift/one plant... x3 shifts= 20 cents).
This is still "Projection"....sales makes 'confirmations'. Investors(early) make profits in 'expectations' and then confirmations. (Don't get bored you people hearing what you already know- "Knowing Future events"'.) The company has a agreement for 36 million to California Biosciences Inc which, IMO, will consume the 'one shift production Nexus'(><). We should hear, according to company expectations. sales starting very soon.
While there are different models of the commerce in the product.. and any International commerce specifically having to do with a refined product, generally speaking, most often, brokerage of the sale includes a deposit model where a Bank holds payment for as much as 30 days... this could be called normal... the shipment is 'checked out' time period reasoning.. before releasing said funds 'completely' and the transaction is finished entirely. The time 'held is variable of course as the relationships are variable.
So.... once 'confirmed' then what will '7 cents' mean to share values? What will 'expectations' mean for 'going forward' '20 cents/3 shifts'? Somewhere between "7x and 20xs"?= one plant. Romanian Plant(Origin) and one might wonder if the Jv partner might take some product early from Nexus?)) will add to cents per share. The biggest jump possible of course is the planned Horizon.. just in reviewing 6 month potentials looking forward..... company states 2xs possibly 3xs Origin and Nexus plants combined.
Fwiw, Charlottes Web missed earnings,,, ><1 billion eval on 25 million is sales, 30 million$ in cash reserves and a questionable eval of 90 million as to assets(questionable because after all, CWEB is doing the valuation. CWEB is going all in on production expansion next year... matching (><) Still's expansion plan(Horizon)... matching the one other plant expansion in America another Colorado company(currently private)... As of now I think of these three companies as the big three outside of Chinese production,, in 2020..
It's going to get interesting here for where Stil can create the 'sale', they will be needing market awareness in the product, don't be surprised in we start getting a lot of low cost statements being out to reflect the ongoing..., jmho, but 200$ Accesswire news releases will likely be the general model to get not just the stock noticed but the company name in the circulation of product providers. A lot of Accesswire news!
Got an answer to a inquiry about Origin:
"Mike, thank you for your inquiry. As you know we have been working on operational permits for our Romanian facility for many months. The facility has been ready to go into production since earlier this year. We have lawyers, consultants, government officials and staff on the ground working through the bureaucracy daily. As we wish the be the first fully licensed facility in the country we have had to receive the blessing of over a dozen different governmental bodies, EPA, Building, Health, DEA, Fire Marshal (local and federal), GMP, Ethanol license to name a few.
Over the many months we checked off each approval, we are now down to the last couple, our attorneys and the government officials we deal with have for some time suggested that we have should all permits in hand this quarter. Based on our daily and weekly progress we have no reason at this point to think this is not the case.
Our staff, and our partners staff, DragonFly Biosciences are focused and dedicated to the task of getting the facility up and running.
I hope this helps answer your question, please feel free to contact me anytime.
Kind regards,
Ilona Kiss
VP Operations"
Good info, imo, so we have more capacity than clients agreements(80 million$) soon.
The general markets for CBD will be expanded greatly.. by then will be well over double present consumption. The E.U. 'Novel foods' will be much better defined, Mexico will be all in... some countries will have 30% of adult populations using in some form, in some manner at some rate.
So far, Stil has kept to schedule, kept to expenses expected. 2021, imo, will entail 20 cents+ per share after everything profit and I'm still hoping for a 4th plant with no JV partner specializing in what is where the industry is leading towards, custom designs/mixes especially in the more rare CBD molecules.
Then end of year 2021 or 2022 selling out that plant @ ><5$ a share for $ and stock- Cannabisin B. Then another Molecule/plant, and another and so on.
Everyone now is still about selling CBDs(general), the Stil management team may settle for a complete company buyout by 2021 after all the hard work and risk.. couldn't blame them.
But some company somewhere is going to catch on to how the Pharmas will buy production facilities so to sell at 100xs markup via regulatory frameworks... I think that is inevitable.
Looks like the Sequoya Cannabis question you had is being answered. 1st revenues.
Todays news answered a number of questions I had, most I put forth to management as no doubt others have. The question on numbers of shifts was right up there in importance.... I wonder still about 'Pelletizer' installation and expected out puts. Which could double+ the stated volumes if not taken into account.
The 3rd party tester is proof of product dependability, 99.6% is a very good purity level, highly competitive. Sampling delivery is the basis for all commerce in this product towards orders, a necessary step. I look forward to knowing how many samples were sent, especially to America via Yetman/Soveriegnports and Canada.
I think we're going to hear good things on acceptance of the product by other/new mass retailers.
As it stands now, it isn't very difficult to see a profit, at a point where current development costs are covered, making net nets positive over the next 3 months possibly.
If so, I would believe Horizon moves forward and 5000 HA(><10 Sq. miles planted in 2020 per company expectations.
https://www.accesswire.com/566210/Stillcanna-Begins-Shipping-CBD-Isolate-Samples-to-New-and-Existing-Customers
A interesting interview with Scnnf's American Import authority Miss Yetman…
https://open.spotify.com/episode/4JZXGkeC3PNLaZTdHOithG
General Manager and Quality Assurance Manager indicates labor input, product output, for ongoing 'mass production'... Technicians were brought onboard last month to run workstations and I think your time prediction(and the company's) is coming to fruition.
Labor and Quality are attained by a ongoing process, which means to me the Nexus plant is producing Isolate daily already!
Next 'Production news' should entail daily/weekly production amounts!
General Manager and Quality assurance brought on board.
https://www.accesswire.com/564633/Stillcanna-Strengthens-Polish-Team
Lets get ready to RUMBLLLLEE
The U.S. can be outside of Pre-booked orders to some degree imo.
I think it is entirely likely that every CBD enterprise in the U.S.A. is going to be contacted, probably directly via mass communications. Why buy higher priced CBD Isolate than can be attained from Stillcanna?
In that grouping of present 'CBD enterprise/s' they have more purchasing power than the 'pre-booked' buyers... just need to access that buying power...……. first start is 'Samples':)
SCNNF is outside the "pot" groups, and is in the "Hemp groups".. the 'Pot' sector is dealing with terrible "P/E" and TTM" results after being in production stages for as many as 3-4 years of production. All the money poured in, hasn't resulted in much ongoing NET NET returns coming out.
Few of the 'Pot/s" even have any Net Nets being positive.
Stillcanna will be more transparent soon as to net profits potential. Next 2-3 months will tell the tale as to this modeling of valuations. I believe Stil can register Net Net profits potential long before a 'Trailing P/E' or even a TTM for 6 months of sales.
All of the few 'Pots" that do have Net Net positives are hugely priced per share... lets see if Stil can join that paradigm!
Likely it is the company took advise to halt, before news. Likely it is that RB Milestone Group LLC that put the news out helped in that suggestion, likely it is that the RB Group which includes
the EMBR Capital Investors expect this.
Remember, Capital 'Funds' expect such things that the general 'pink sheeters do not seem to need/care about, Fwiw, Stil will draw more Capital Investors at some point.. as like you mentioned in 'earnings statements' and 'up listing'... all need a track record of 'fairness' in Corporate Guidance- 'significant changes'.
I'm not saying your opinion is wrong, simply adding color for reason more advanced companies halt, 'significant changes'. I would rather appreciate careful 'fairness doctrine', than disdain it.
While it is silly to make links further, the EMBR and RB have connections all the way up to Morgan Stanley and Morgan Stanley is present in most every high level Hemp meeting in the Western World.
We are seeing proper guidance imo.
I presume you found the News item?
'Stillcanna's Nexus Facility Produces Pharmaceutical Grade CBD Isolate in Poland'
https://www.accesswire.com/563591/Stillcanna-Produces-Premium-Grade-CBD-Isolate-in-Poland
Anyway I found it significant. Got a couple more today. With 3 different exchanges listing the stock maybe that had something to do with the timing and halt?
But the opening back up messed up some, should have waited till this morning, about a half dozen trades from .33- .41 ran in a second- some Broker Dealers were not prepared and I'm surprised a reset didn't happen.
So now the Company has every form of CBD enabled.. including the Isolate, imo the item most revs will come from.
10-21 short position report:
STILLCANNA INC. STIL CSE 33320 -43422
So while Broker dealers are still selling shares they do not have daily... The End of Reporting Period short position is down 90% from where it was just two months ago.
Just came online! That's a surprise!
Stil trades in Germany(and Canada and U.S.) so I could guess it will open tomorrow.
Non-alcohol CBD-infused beverages in Canada should be on shelfs mid December... while some deals are already made one has to ask what getting Stillcanna CBD Isolate pricing below other suppliers will mean.. to those deals. Because 'spring water' and a bottle with a label costs next to nothing.
Currently I see a vast opportunity and Stil being a real disrupter!
I foresee a lot of orders from Switzerland and Germany, even Chinese 'backdoors' going to Poland in the next 120 days><.
Lest we forget,
https://sovereignport.com/testimonials
https://sovereignport.com/find-product … 2500 potential buyers!
Weekly cbd product alerts
CBD Products
Our list of CBD products are separated by continent and region - the list is active and is updated weekly by the seller.
Pricing
A range of pricing is included - the final price is decided by the seller and will most likely be determined by quantity.
Minimum/ Maximum
Total quantities and minimum orders will also be included.
GET THE CBD PRODUCT LIST
Connect Today
Sign-up for your weekly CBD product list to get:
Current Worldwide Product
Pricing Trends
Regional Trends
Closed Deals
Existing customer orders looks like 24 million$ worth per year!
I'll bet quite a few additional companies will be getting a Stillcanna profile with testing results and pricing structures soon.
Remember, EOY 2020 the plan for 100,000 Kilos plus production capacity!
Stillcanna Produces Premium Grade CBD Isolate in Poland
Monday, October 21, 2019 12:43 PM
Stillcanna's Nexus Facility Produces Pharmaceutical Grade CBD Isolate in Poland
VANCOUVER, BC / ACCESSWIRE / Monday October 21, 2019 / Stillcanna Inc. (OTC:SCNNF) (CSE:STIL) (FRANKFURT:A2PEWA) ("STIL" or the "Company") is pleased to announce that its NEXUS extraction facility has produced bulk CBD isolate from hemp harvested by Olimax, the Company's farming subsidiary in Poland.
With the use of Stillcanna's proprietary operating procedures, CBD rich honey oil distillate is further purified into pharmaceutical grade CBD isolate. The successful manufacturing of the CBD isolate in the NEXUS facility is THC, pesticide and heavy metal free.
The Company is expected to begin shipping samples of its pharmaceutical grade CBD isolate to its current and potential customers as a part of its standard sales process this quarter. The Company is still on track for commercial production of CBD this quarter to begin fulfilling its contractual agreements.
https://www.accesswire.com/563591/Stillcanna-Produces-Premium-Grade-CBD-Isolate-in-Poland
Something is afoot!
SOURCE Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions
VANCOUVER, Oct. 21, 2019 /CNW/ - The following issues have been halted by IIROC:
Company: StillCanna Inc.
CSE Symbol: STIL (All Issues)
Reason: At the request of the Company Pending News
Halt Time (ET): ?8?:?00?:00 AM
IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.
One of the best North American Industry conferences,The 3rd Institutional Capital & Cannabis Conference (East), kicks off October 21st.
https://www.imn.org/investment-management/conference/IC3-
Institutional-Capital-Cannabis-East/highlight/30044
To help explain the unavoidable Institutional involvement by Capital Investment groups, these are some of the Attendees;
4Front Ventures, CIO
4Front Ventures, ECD & Investor Relations
AB Bernstein, Private Wealth Management
Abacus Health Products, Director of Business Development
ADVFN, Account Executive
Aegis Capital Corp, Senior Vice President
Aegis Capital Group, Managing Director
Aegis Capital Group, Vice President
AFI Capital Partners, Managing Director
Agri-Kind LLC, CEO
Agronomed Pharmaceuticals LLC, Development
Agronomed Pharmaceuticals LLC, CFO
Aleph Capital, Chief Investment Officer
Alliance Holdings, Director of Acquisitions
Alpine Growth Capital Advisors, President
Alta Capital, President
Altitude Investment Management, LLC, Partner
American Harvest Inc, CEO
American Harvest Inc, President
Archer & Greiner, PC, Marketing & Business development Coordinator
Arena Investors, Managing Director, Structured Finance
Art Assets, Founder and CEO
Artemis Capital Advisory, Managing Partner
Artery Pay, CEO
Banc of California, Senior Vice President Head of Business Strategy
BDS Analytics, Managing Director
BDS Analytics, CEO
BDS Analytics, Managing Director
Beach Point Capital, Managing Director
Bloom Farms, Business Development
BMB Advisors, Vice Chairman
BreakWater Venture Capital, Managing Partner
Brown Gibbons Lang & Company, VP
Butler Global Partners, Managing Principal
Canna Advisors, CEO & Co-Founder
Cannabis Trade Federation, CEO
CannaFAME/Higher Frequencies, Inc, CEO/Founder
CannaGather, Founder
CannaMLS.com, CEO
Casoro Capital, CEO
CB Capital Concierge, Founder
Citadel SPV LLC, CEO
Citadel SPV LLC, Senior Managing Director
Cole Schotz P.C., Chief Marketing Officer
Cole Schotz P.C., Member
Colley Asset Management, Money Manager
Columbia Care, CEO
Connolly Financial Advisors, Financial Advisor
Cowen, Managing Director
Cowen, Director, Marketing & Communications
Cowen and Company, Managing Director
Cresco Capital Partners, Managing Principal
Cresco Capital Partners, Managing Director
Cresta Management Services, Director
Cresta Management Services, Director
Cresta Management Services, CEO
CVII UK, Director
Derene Family Office, Principal
Dickinson Wright, Deputy CEO - Finance
Dickinson Wright PLLC, Member
Dickinson Wright PLLC, Member
Elizabethtown College, Trustee
Ello Capital, Director
Etain, LLC, CEO
Euromoney Publications plc, Publisher
Foley Hoag LLP, Attorney
GlassRatner, Associate
GlassRatner Advisory & Capital Group, Senior Managing Director
Gleam Law, Attorney
Global Real Assets, Senior Consultant
Global Realty Capital LLC, Founder/CEO
Goodwin Procter LLP, Associate
GRA Capital Holdings, Founder
Greenspoon Marder, CMO
GreenspoonMarder, Shareholder
GreenWave Advisors, Founder & Managing Partner
Grupo Flor, CEO
Grupo Flor, CEO
Harvest One, SVP Corporate & Public Affairs
Harvest One Cannabis, VP Investor Relations
Hawk Investments, L.P., Associate
Hawk Investments, L.P., CIO
HCM Ventures, President
Hedgeye Risk Management, Equity Analyst
Her Highness, Co-Founder
Hiller, PC, Partner
Hypur Ventures, Managing Partner
Intrinsic Capital Partners, Vice President
Investor, Investor
Investors Hub/ADVFN, Account Director
Ironwood, MD
Ladenburg Thalmann, VP Equity Research
Ladenburg Thalmann & Co. Inc, Head of Capital Markets
Ladenburg Thalmann & Co. Inc, Head of Capital Markets
LPL Financial, Financial Advisor
Luesink Stenstrom Financial, Financial Advisor
Marijuana Leadership Campaign, Executive Director
Marijuana Policy Project, Executive Director
MassMutual, Wealth Management Advisor
Mercadyne Funds, Managing Principal
Merida Capital Partners, Partner
Merril Lynch, Pierce, Fenner, and Smith, Senior Financial Advisor
Merrill Lynch, SVP, Wealth Management Advisor
Merrill Lynch & Co. Inc., Vice President
Merrill Lynch Wealth Management, Financial Advisor
Merrill Lynch Wealth Management, Senior Vice President
Merrill Lynch Wealth Management, Financial Advisor
Merrill Lynch Wealth Management, Senior Portfolio Advisor
Merrill Lynch Wealth Management, Financial Advisor
Merrill Lynch Wealth Management, Senior Portfolio Manager
Merrill Lynch Wealth Management, Financial Advisor
Merrill Lynch, Pierce, Fenner & Smith Inc., Senior Vice President
Merrimac Corp, Chief Financial Officer
Merrimac Corp, Analyst
Morgan Stanley, Financial Advisor
Morgan Stanley, Senior Vice President
Morgan Stanley, Financial Advisor
Morgan Stanley, Wealth Manager
Morgan Stanley Private Wealth Management, Director
Morgan Stanley Private Wealth Management, Private Wealth Advisor
Morgan Stanley Private Wealth Management, Family Wealth Director, VP, CFP
Morgan Stanley Wealth Management, Associate
Morgan Stanley Wealth Management, Portfolio Associate
Morgan Stanley Wealth Management, Financial Advisor, Alternative Investments Director
Morgan Stanley Wealth Management, Portfolio Management Director
Morgan Stanley Wealth Management, Financial Advisor
Morgan Stanley Wealth Management, Senior Vice President
Morgan Stanley Wealth Management, Vice President
Morgan Stanley Wealth Management, Managing Director, Senior Portfolio Manager
Morgan Stanley Wealth Management: The Blair Group, Executive Director, Portfolio Management Director, Family Wealth Advisor
Morgan Stanley Wealth Management: The Blair Group, Financial Advisor, VP
New Breed W, Founder
New Frontier Data, Chief Knowledge Officer
New Frontier Data, Founder & CEO
NewLake Capital Partners, Inc., CEO
NewLake Capital Partners, Inc., Director of Acquisitions
NewLake Capital Partners, Inc., CEO
NFS Leasing, Vice President, Business Development
Northern Swan Holdings, CEO
Old Apple Farm, Founder
Oppenheimer & Co, Financial Advisor
Oppenheimer & Co. Inc., Senior Director-Investments
Oppenheimer & Co. Inc., Financial Advisor
Oppenheimer & Co. Inc., Senior Director-Investments
Orthodontist, Orthodontist
P.S. Harris & Co., Principal
Park Avenue Securities LLC, Financial Advisor
passport cannabis, CEO
Pelorus Equity Group, President
Pelorus Equity Group, Investor Relations
Phyto Partners LP, Co-Founder & Managing Director
Politico, Cannabis policy reporter
Private Investor, Private Investor
Private Investor, Private Investor
PureVita Labs, Founder/CEO
Quiver Financial, CIO
RBC Wealth Management, Financial Advisor
Reorg M&A, Lead Reporter, Regulated Industries
Royale Asset Management, Investment Advisofr
RWN Management, LLC, Vice President
RWN Management, LLC, Vice President
Salveo Capital, Managing Partner
Salveo Capital, Managing Partner
Sanavest Equity, LLC, Principal
Shire Capital Advisors, Partner
Shryne Group, Chairman
Shryne Group, Co-Founder & CEO
Shryne Group, Chief Communications Officer
Simons Financial Network, Founder
Sixiang Holding, Managing Director
Slome Capital LLC., President
Stanley Wealth Management, Financial Advisor
Strategies for Wealth, Financial Advisor
TAG Associates, President
Textron Financial Corporation, Chief Investment Officer of Pension Investments
The Arcview Group, General Partner
The Arcview Group, -
The Bates Caputo Group, Senior Financial Advisor
The Blinc Group, Chief Executive Officer
The Blinc Group, CEO
The New York State Senate, New York State Senator
The United States House of Representatives, Congressman Ohio's 14th District
Tikun Olam, MD
Treehouse REIT, CEO
Trichome Capital Partners S.L., Advisor
Tuatara Capital LP, Partner
Tuatara Capital LP, CIO
Tuscan Holdings, President, CFO & Director
tZERO, Head of Business Development
UBS, VP Wealth Mgmt, Portfolio Manager PMP
UNConsulting, Managing Director
Value Investment Professionals, Managing Member
Value Investment Professionals, Managing Member
Viridian Capital Advisors, LLC, President
Viridian Capital Advisors, LLC, President
WelCan Capital, Partner
Zuber Lawler, Managing Partner
Track B 1:45 pm
'Looking to Opportunities in Europe and Other International Markets
Europe is on track to become the world’s largest legal cannabis market with updated projections of a $70 billion medical market and a potential recreational market worth $155 billion by 2028. Many American and Canadian cannabis operators are beginning to enter Europe and other nascent markets with considerable potential for growth. This session will address the many opportunities across a range of regions, while also discussing the challenges associated with different legal systems, patient access, cultivation supply and logistics.'
Soon eyes(and deep pockets) will be on Stillcanna.
Regulation headwinds exist, and are weakening, FAST. Good timing on Stillcanna's part. The company leadership is not involved nor wishes to be in the psychedelic side of Cannabis and will be destroying the Chromophotograph removed THC Delta 9 portions from Hemp processing.... the Demonization of Cannabis does put CDB producers under some of the headwinds in regulatory schemes.
In addition to Canada's remarkable changes on the 17th('Cannabis 2.0'), Mexico made a big push publicly, same day..
'Several Mexican Senate committees unveiled draft legislation late on Thursday to legalize marijuana.
Leaders of the Health, Justice, Public Security and Legislative Studies Committees announced last week that they would remain in permanent session to finalize the legalization bill ahead of a coming Supreme Court deadline.
The court determined last year that the country’s ban on personal cannabis consumption and cultivation is unconstitutional, though lawmakers now want to go even further by legalizing commercial production and sales.
The committees are expected to formally vote on the legislation in the coming days, after which point it will head to the full Senate and then the Chamber of Deputies. Leaders said a vote in the legislature could occur before the end of the month, though it’s possible they could ask the Supreme Court for a deadline extension.'
Also in the U.S... same day..
'Four Northeastern Governors Team Up on Vaping and Marijuana Standards'..... (there were a couple other Governors present also)
this will, imo, push the American FDA to comply with the American Senate requests for a uniform set of rules to be completed by January.
These things, same day, are not co-incidental. 'sea change' is happening, the United States sees Mexico and Canada changing dramatically and cannot have both Northern and Southern bordering Nations to America be potential entry points OF THEIR LEGAL CANNABIS.
I'm watching for E.U. Commission to follow suit:)
Seatbelts on, arms and legs in the vehicle folks.
Charlottes web is going to be producing CBDs for Canada in 'edibles'..... boy are they going to take a hurting with Stil going online!
Fwiw, "Isolate" is ready to be mixed with many oils, 'fat soluble'.
I looked at one Isolate retail seller getting ><27$U.S. per gram, if 7 grams or more are ordered=27K$ for a Kilo priced out retail 7gram containers, just one retail outfit so to say. Seems "Isolate" is better appreciated than regular CBDs in general Tinctures by pricing on most online sites.
I understand the Stil teams excitement factor better every day.
Yesterday 'Cannabis 2.0'(legalization of marijuana derivatives including edibles, beverages, extracts and vape pens) has arrived. Canada is set to legalize edibles, beverages, and topicals, creating sizable opportunity for growth. Interesting to note, according to analysts at Deloitte, up to 60% of Canadians would use such cannabis edible products.
New products, edibles, should be on shelfs in December, Deloitte has polled a 35% increase in CBD consumption and the rest of products(Delta 9) averaging 50-100% more use.
So essentially one country, Canada has moved forward... time for you to go see your Doctor again! Gummy bears anyone?
I also had questioned about other equipment, so to understand development flow:
"Using ultrasonic waves to nano size CBD isolate is the standard method but you still need to start with a powder material prior to nano sizing. We have not installed the nano sizer yet, on the scale of things and in the scheme of things it is a relatively inexpensive off the shelf piece of equipment and not greatly significant compared to the engineering work and design we have done so far.
We have multiple buildings on site and have a separate space /building for hemp storage / pelletizing etc "the dirty area".
We in building Nexus concentrated on being able to provide bulk CBD isolate first, then distillate, water soluble , nano etc will all come relatively quickly.
My favorite part, '...being able to provide bulk CBD isolate first..':)))
I nagged, and the founder replied..
In our Polish operations we are ramping daily and as stated intend to be in commercial production this quarter, every day we are increasing our potential capacities as we fine tune the various steps from raw hemp to our initial final product being Isolate. We will through public disclosure over the next short term keep our investors up to date with our continued progress Our equipment and procedures are functioning as designed and we as a company are very excited !!!